Efficacy of PEEK Acuity Versus ETDRS Chart for Assessment of Visual Acuity and Refractive Error
NCT ID: NCT06913491
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
51 participants
OBSERVATIONAL
2025-03-20
2026-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Validity, Reliability, and Feasibility of Two Smartphone Applications for Testing the Visual Acuity
NCT04936100
Visual and Functional Assessment in Low Vision Patients
NCT01876147
Rapid Computerized Visual Acuity Test
NCT05447845
Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart
NCT01622816
Towards Worldwide Comparability of Visual Acuity Assessment
NCT01312662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older.
* Individuals with normal vision or those with refractive error who had their corrected glasses.
* Individuals who are willing and able to provide written informed consent to participate in the study.
Exclusion Criteria
* Individuals with vision deprivation due to corneal opacities, cataracts, glaucoma, retinal, and optic nerve pathologies.
* Postoperative/intraoperative complications.
* Have received mydriatic drops.
* Individuals who cannot achieve normal visual acuity with corrective lenses (glasses or contact lenses).
* Individuals with neurological conditions affecting vision
* Individuals unable to cooperate with visual acuity testing due to cognitive impairments or language barriers.
* Individuals who have had refractive surgery or other eye treatments within the past 6 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Superior University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Naveed Babur
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eagle Eyes Relief Trust FF120, Divine mega 2, new airport road
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MSRSW/Batch-Fall23/803
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.